Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more
Market Cap & Net Worth: Integrated Diagnostics Holdings plc (IDGXF)
Integrated Diagnostics Holdings plc (PINK:IDGXF) has a market capitalization of $187.19 Million ($187.19 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #19464 globally and #7152 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Integrated Diagnostics Holdings plc's stock price $0.32 by its total outstanding shares 581326272 (581.33 Million).
Integrated Diagnostics Holdings plc Market Cap History: 2019 to 2025
Integrated Diagnostics Holdings plc's market capitalization history from 2019 to 2025. Data shows change from $2.07 Billion to $187.19 Million (-36.19% CAGR).
Integrated Diagnostics Holdings plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Integrated Diagnostics Holdings plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Integrated Diagnostics Holdings plc's market cap is 0.03 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.18x
Integrated Diagnostics Holdings plc's market cap is 0.18 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $2.07 Billion | $2.23 Billion | $510.93 Million | 0.93x | 4.05x |
| 2020 | $524.12 Million | $2.66 Billion | $594.01 Million | 0.20x | 0.88x |
| 2021 | $871.99 Million | $5.22 Billion | $1.41 Billion | 0.17x | 0.62x |
| 2022 | $352.87 Million | $3.61 Billion | $541.11 Million | 0.10x | 0.65x |
| 2023 | $195.91 Million | $4.12 Billion | $510.30 Million | 0.05x | 0.38x |
| 2024 | $198.23 Million | $5.72 Billion | $1.08 Billion | 0.03x | 0.18x |
Competitor Companies of IDGXF by Market Capitalization
Companies near Integrated Diagnostics Holdings plc in the global market cap rankings as of March 19, 2026.
Key companies related to Integrated Diagnostics Holdings plc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Integrated Diagnostics Holdings plc Historical Marketcap From 2019 to 2025
Between 2019 and today, Integrated Diagnostics Holdings plc's market cap moved from $2.07 Billion to $ 187.19 Million, with a yearly change of -36.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $187.19 Million | -5.57% |
| 2024 | $198.23 Million | +1.19% |
| 2023 | $195.91 Million | -44.48% |
| 2022 | $352.87 Million | -59.53% |
| 2021 | $871.99 Million | +66.37% |
| 2020 | $524.12 Million | -74.64% |
| 2019 | $2.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Integrated Diagnostics Holdings plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $187.19 Million USD |
| MoneyControl | $187.19 Million USD |
| MarketWatch | $187.19 Million USD |
| marketcap.company | $187.19 Million USD |
| Reuters | $187.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.